Lymph Node Ratio Predicts Recurrence in Papillary Thyroid Cancer

ways in lymph node ratio be in

[1]  Herb Chen,et al.  Preoperative ultrasonography findings predict the need for repeated surgery in papillary thyroid cancer. , 2012, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[2]  J. Ricarte-Filho,et al.  Papillary thyroid carcinomas with cervical lymph node metastases can be stratified into clinically relevant prognostic categories using oncogenic BRAF, the number of nodal metastases, and extra-nodal extension. , 2011, Thyroid : official journal of the American Thyroid Association.

[3]  I. Ganly,et al.  Rising incidence of second cancers in patients with low‐risk (T1N0) thyroid cancer who receive radioactive iodine therapy , 2011, Cancer.

[4]  S. Mocellin,et al.  Validation of the prognostic value of lymph node ratio in patients with cutaneous melanoma: a population-based study of 8,177 cases. , 2011, Surgery.

[5]  R. Kloos.  Thyroid cancer recurrence in patients clinically free of disease with undetectable or very low serum thyroglobulin values. , 2010, The Journal of clinical endocrinology and metabolism.

[6]  R. Burney,et al.  Influence of prophylactic central lymph node dissection on postoperative thyroglobulin levels and radioiodine treatment in papillary thyroid cancer. , 2010, Surgery.

[7]  John T. Chang,et al.  The effectiveness of radioactive iodine for treatment of low-risk thyroid cancer: a systematic analysis of the peer-reviewed literature from 1966 to April 2008. , 2010, Thyroid : official journal of the American Thyroid Association.

[8]  P. Schneider,et al.  An Evaluation of Lymph Node Yield and Lymph Node Ratio in Well-Differentiated Thyroid Carcinoma , 2010, The American surgeon.

[9]  A. Miyauchi,et al.  Prognosis of patients with papillary thyroid carcinoma having clinically apparent metastasis to the lateral compartment. , 2009, Endocrine journal.

[10]  D. Steward,et al.  The pros and cons of prophylactic central compartment lymph node dissection for papillary thyroid carcinoma. , 2009, Thyroid : official journal of the American Thyroid Association.

[11]  V. Zaydfudim,et al.  The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma. , 2008, Surgery.

[12]  K. Schuff,et al.  Efficacy of Nodal Dissection for Treatment of Persistent/Recurrent Papillary Thyroid Cancer , 2008, The Laryngoscope.

[13]  E. Babin,et al.  Macroscopic lymph-node involvement and neck dissection predict lymph-node recurrence in papillary thyroid carcinoma. , 2008, European journal of endocrinology.

[14]  Douglas B. Evans,et al.  Role of lymph node dissection in primary surgery for thyroid cancer. , 2007, Journal of the National Comprehensive Cancer Network : JNCCN.

[15]  K. McMasters,et al.  Factors Determining Adequacy of Axillary Node Dissection in Breast Cancer Patients , 2007, The breast journal.

[16]  N. Wada,et al.  Microscopic regional lymph node status in papillary thyroid carcinoma with and without lymphadenopathy and its relation to outcomes , 2007, Langenbeck's Archives of Surgery.

[17]  S. Sidhu,et al.  Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer. , 2006, Surgery.

[18]  E. Baudin,et al.  Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis. , 2005, The Journal of clinical endocrinology and metabolism.

[19]  A. Miyauchi,et al.  Preoperative Ultrasonographic Examination for Lymph Node Metastasis: Usefulness when Designing Lymph Node Dissection for Papillary Microcarcinoma of the Thyroid , 2004, World Journal of Surgery.

[20]  S. Takao,et al.  Distribution of lymph node micrometastasis in pN0 well-differentiated thyroid carcinoma. , 2002, Surgery.

[21]  P. Ladenson,et al.  Prospective multicenter study of thyroiscarcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group. , 1998, Cancer.

[22]  B. Nilsson,et al.  Improved Survival of Patients with Papillary Thyroid Cancer after Surgical Microdissection , 1996, World Journal of Surgery.

[23]  E. Bergstralh,et al.  Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. , 1993, Surgery.

[24]  B. Cady,et al.  An expanded view of risk-group definition in differentiated thyroid carcinoma. , 1988, Surgery.

[25]  E. Mazzaferri,et al.  Papillary thyroid carcinoma: a 10 year follow-up report of the impact of therapy in 576 patients. , 1981, The American journal of medicine.

[26]  M. van Glabbeke,et al.  A prognostic index for thyroid carcinoma. A study of the E.O.R.T.C. Thyroid Cancer Cooperative Group. , 1979, European journal of cancer.

[27]  S. Noguchi,et al.  Papillary carcinoma of the thyroid I. Developing pattern of metastasis , 1970, Cancer.